Comparison of Overall Obesity and Abdominal Adiposity in Predicting Chronic Kidney Disease Incidence Among Adults

Published:March 04, 2009DOI:


      Epidemiological data on the association between different aspects of adiposity and the risk for chronic kidney disease (CKD) in a cohort are limited. We compared the independent power of waist circumference (WC), waist-to-hip ratio (WHR), and body mass index (BMI) in predicting CKD in a large cohort of adults.


      This was a population-based cohort study.

      Setting, Participants, and Measurements

      A representative sample of 3107 subjects (1309 men and 1798 women), aged over 20 years, and free of CKD at baseline, was followed for 7 years.


      We estimated glomerular filtration rate (GFR) by using the abbreviated equation from the Modification of Diet in Renal Disease Study, and defined CKD as an estimated GFR of less than 60 mL/min/1.73 m2. Adjusted relative hazards of CKD were modeled using Cox proportional hazards regression, including BMI, WC, and WHR as risk factors.


      During the 7-year follow-up (median of 2183 days), 13.5% of participants (n = 419) developed CKD. The WC was positively related to risk of CKD, after multivariable adjustment for age, sex, smoking, menopause, physical activity, blood pressure, prevalent and incident diabetes, and change in WC during study period: Hazard ratios for CKD incidence were 1.00 (reference), 1.60 (95% CI: 1.06, 2.42), 1.86 (0.95 CI: 1.21, 2.85), and 1.88 (0.95 CI: 1.17, 3.01) for WC categories 1 to 4, respectively (P for trend < .02). The WHR was not independently associated with CKD. The rate of GFR decline (measured in mL/min/1.73 m2/year) was associated with baseline waist categories: regression coefficient for 1 SD increase in WC = −0.18 (0.95 CI:−0.28, −0.07). Based on Harrell's measure of concordance statistics, baseline WC was a better predictor of CKD than WHR (P < .05) and BMI (P < .05).


      Abdominal adiposity measured with WC, irrespective of general adiposity, is a more important determinant of CKD risk in adults than are WHR and BMI.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Renal Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Levey A.S.
        • Coresh J.
        • Balk E.
        National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
        Ann Intern Med. 2003; 139: 137-147
        • Mahdavi-Mazdeh M.
        • Zamyadi M.
        • Nafar M.
        Assessment of management and treatment responses in haemodialysis patients from Tehran province.
        Iran. Nephrol Dial Transplant. 2008; 231: 288-293
        • Coresh J.
        • Byrd-Holt D.
        • Astor B.C.
        • Eggers P.W.
        • Lacher D.A.
        • Hostetter T.H.
        Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000.
        J Am Soc Nephrol. 2005; 16: 180-188
        • Hayden M.R.
        • Whaley-Connell A.
        • Sowers J.R.
        Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.
        Am J Nephrol. 2005; 256: 553-569
        • US Renal Data System
        USRDS 2005 annual data report: atlas of end-stage renal disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2005
        • Wiggins K.J.
        • Johnson D.W.
        The influence of obesity on the development and survival outcomes of chronic kidney disease.
        Adv Chronic Kidney Dis. 2005; 12: 49-55
        • Bergström A.
        • Hsieh C.C.
        • Lindblad P.
        • Lu C.M.
        • Cook N.R.
        • Wolk A.
        Obesity and renal cell cancer—a quantitative review.
        Br J Cancer. 2001; 85: 984-990
        • de Jong P.E.
        • Verhave J.C.
        • Pinto-Sietsma S.J.
        • Hillege H.L.
        Obesity and target organ damage: the kidney.
        Int J Obes Relat Metab Disord. 2002; 26: S21-S24
        • Azizi F.
        • Rahmani M.
        • Emami H.
        • Madjid M.
        Tehran Lipid and Glucose Study: rationale and design.
        CVD Prev. 2000; 3: 242-347
        • Azizi F.
        • Ghanbarian A.
        • Madjid M.
        • Rahmani M.
        Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study, 1999-2000.
        J Hum Hypertens. 2002; 16: 305-312
        • Ainsworth B.E.
        • Jacobs J.R.
        • Leon A.S.
        Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire.
        Med Sci Sports Exerc. 1993; 25: 92-98
        • Franz M.J.
        Medical nutrition therapy for diabetes mellitus and hypoglycemia of nondiabetic origin.
        in: Mahan L.K. Stump S.E. Krause's Food, Nutrition and Diet Therapy. 11th ed. W.B. Saunders Co, Philadelphia2004: 799
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Levey A.S.
        • Coresh J.
        • Greene T.
        • et al.
        Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate.
        Ann Intern Med. 2006; 1454: 247-254
      1. National Institutes of Health, National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity: The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.
        National Institutes of Health, Bethesda, MD2000
        • Seidell J.C.
        • Kahn H.S.
        • Williamson D.F.
        • Lissner L.
        • Valdez R.
        Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care.
        Am J Clin Nutr. 2001; 73: 123-126
        • Seidell J.C.
        • Perusse L.
        • Despres J.P.
        • Bouchard C.
        Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study.
        Am J Clin Nutr. 2001; 74: 315-321
        • Rankinen T.
        • Kim S.Y.
        • Perusse L.
        • Despres J.P.
        • Bouchard C.
        The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis.
        Int J Obes Relat Metab Disord. 1999; 23: 801-809
        • Taylor R.W.
        • Keil D.
        • Gold E.J.
        • Williams S.M.
        • Goulding A.
        Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves.
        Am J Clin Nutr. 1998; 67: 44-49
        • Chen M.M.
        • Lear S.A.
        • Gao M.
        • Frohlich J.J.
        • Birmingham C.L.
        Intraobserver and interobserver reliability of waist circumference and the waist-to-hip ratio.
        Obes Res. 2001; 9: 651
        • Stengel B.
        • Tarver-Carr M.E.
        • Powe N.R.
        • Eberhardt M.S.
        • Brancati F.L.
        Lifestyle factors, obesity and the risk of chronic kidney disease.
        Epidemiology. 2003; 14: 479-487
        • Kasiske B.
        • Napier J.
        Glomerular sclerosis in patients with massive obesity.
        Am J Nephrology. 1985; 5: 45-50
        • Brenner B.M.
        Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.
        Kidney Int. 1983; 23: 647-655
        • Hostetter T.H.
        • Rennke H.G.
        • Brenner B.M.
        Compensatory renal hemodynamic injury. A final common pathway of residual nephron destruction.
        Am J Kidney Dis. 1982; 1: 310-314
        • Brenner B.M.
        • Meyer T.W.
        • Hostetter T.H.
        Dietary protein intake and the progressive nature of kidney disease. The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
        N Engl J Med. 1982; 307: 652-659
        • Purkerson M.L.
        • Hoffsten P.E.
        • Klahr S.
        Pathogenesis of the glomerulopathy associated with renal infarction in rats.
        Kidney Int. 1976; 9: 407-417
        • Culleton B.F.
        • Larson M.G.
        • Evans J.C.
        • et al.
        Prevalence and correlates of elevated serum creatinine levels. The Framingham Heart Study.
        Arch Intern Med. 1999; 159: 1785-1790
        • Pinto-Sietsma S.J.
        • Navis G.
        • Janssen W.M.
        • de Zeeuw D.
        • Gans R.O.
        • de Jong P.E.
        A central body fat distribution is related to renal function impairment, even in lean subjects.
        Am J Kidney Dis. 2003; 41: 733-741
        • Chen J.
        • Muntner P.
        • Hamm L.L.
        • et al.
        The metabolic syndrome and chronic kidney disease in US adults.
        Ann Intern Med. 2004; 140: 167-174
        • Pi-Sunyer F.X.
        The obesity epidemic: pathophysiology and consequences of obesity.
        Obes Res. 2002; 10: 97S-104S
        • Hall J.E.
        • Kuo J.J.
        • da Silva A.A.
        • de Paula R.B.
        • Liu J.
        • Tallam L.
        Obesity-associated hypertension and kidney disease.
        Curr Opin Nephrol Hypertens. 2003; 12: 195-200
        • Nagase M.
        • Yoshida S.
        • Shibata S.
        • et al.
        Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
        J Am Soc Nephrol. 2006; 17: 3438-3446
        • Axelsson J.
        • Stenvinkel P.
        Role of fat mass and adipokines in chronic kidney disease.
        Curr Opin Nephrol Hypertens. 2008; 17: 25-31
        • Manjunath G.
        • Sarnak M.J.
        • Levey A.S.
        Prediction equations to estimate glomerular filtration rate. An update.
        Curr Opin Nephrol Hypertens. 2001; 10: 785-792
        • Lin J.
        • Knight E.L.
        • Hogan M.L.
        • Singh A.K.
        A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease.
        J Am Soc Nephrol. 2003; 14: 2573-2580
        • Hallan S.
        • Asberg A.
        • Lindberg M.
        • Johnsen H.
        Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay.
        Am J Kidney Dis. 2004; 44: 84-93